Stay updated on Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page footer now includes Revision: v3.3.3, and the previous HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T20:20:19.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision note updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:57:02.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The notice about government funding and operating status has been removed from the page. This information is administrative and does not affect the study details, eligibility criteria, or contact information.
    Difference
    0.4%
    Check dated 2025-11-19T01:44:35.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Note added to Study Record Dates showing the last known status as reported by National Cancer Centre, Singapore on 2023-10 and marked as Verified Unknown status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-04T04:31:17.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The new screenshot shows minor UI refinements such as spacing, typography, and small layout adjustments across sections; there are no changes to core study details like eligibility criteria, endpoints, enrollment, or location. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-28T02:36:25.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T15:58:48.000Z thumbnail image

Stay in the know with updates to Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.